Operating

Intangible Amortization

Neurocrine Biosciences Intangible Amortization decreased by 90.9% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.0%, from $1.00M to $100.00K.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase often follows a period of aggressive M&A activity, reflecting the cost of integrating acquired intellectual property.

Detailed definition

This metric tracks the systematic write-down of the value of acquired intangible assets, such as patents, trademarks, an...

Peer comparison

Common in companies with high M&A activity; peers in the medical device sector typically show consistent levels.

Metric ID: amortization_of_intangibles

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$500.00K$900.00K$900.00K$900.00K$800.00K$900.00K$900.00K$900.00K$900.00K$1.00M$1.00M$1.00M$1.10M$100.00K
QoQ Change+80.0%+0.0%+0.0%-11.1%+12.5%+0.0%+0.0%+0.0%+11.1%+0.0%+0.0%+10.0%-90.9%
YoY Change+60.0%+0.0%+0.0%+0.0%+12.5%+11.1%+11.1%+11.1%+22.2%-90.0%
Range$0.00$1.10M
Avg YoY Growth+3.8%
Median YoY Growth+11.1%

Intangible Amortization at Other Companies

Frequently Asked Questions

What is Neurocrine Biosciences's intangible amortization?
Neurocrine Biosciences (NBIX) reported intangible amortization of $100.00K in Q1 2026.
How has Neurocrine Biosciences's intangible amortization changed year-over-year?
Neurocrine Biosciences's intangible amortization decreased by 90.0% year-over-year, from $1.00M to $100.00K.
What does intangible amortization mean?
The non-cash expense related to the gradual reduction in value of acquired intangible assets.